HomeBOLT • NASDAQ
add
Bolt Biotherapeutics Inc
Previous close
$0.50
Day range
$0.49 - $0.52
Year range
$0.48 - $1.56
Market cap
19.19M USD
Avg Volume
180.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 1.14M | -54.87% |
Operating expense | 3.80M | -34.05% |
Net income | -15.18M | 6.65% |
Net profit margin | -1.33K | -106.83% |
Earnings per share | -0.40 | 6.98% |
EBITDA | -16.00M | 9.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 53.80M | -55.06% |
Total assets | 109.33M | -37.65% |
Total liabilities | 37.30M | -20.79% |
Total equity | 72.03M | — |
Shares outstanding | 38.27M | — |
Price to book | 0.27 | — |
Return on assets | -35.21% | — |
Return on capital | -42.17% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -15.18M | 6.65% |
Cash from operations | -13.97M | 16.62% |
Cash from investing | 17.14M | 35.39% |
Cash from financing | 0.00 | — |
Net change in cash | 3.17M | 177.54% |
Free cash flow | -8.84M | -2.27% |
About
Founded
2015
Headquarters
Website
Employees
100